Cadonilimab (AK104) is a humanized antibody engineered from the IgG1 scaffold and targets PD1/CTLA4. It is utilized in the research of metastatic cervical cancer [1] [2].
CAS Number:
[2394841-59-7]
* VAT and and shipping costs not included. Errors and price changes excepted